Claims
- 1. A wafer of viscoelastic material adapted to hold an intraocular lens, wherein said viscoelastic material is chondroitin sulfate or a mixture of chondroitin sulfate and a hyaluronate.
- 2. The wafer set forth in claim 1, wherein said viscoelastic material is chondroitin sulfate.
- 3. The wafer set forth in claim 2, wherein said viscoelastic material is sodium chondroitin sulfate.
- 4. The wafer set forth in claim 1, wherein said viscoelastic material is a mixture of chondroitin sulfate and a hyaluronate.
- 5. The wafer set forth in claim 4, wherein said viscoelastic material is a mixture of sodium chondroitin sulfate and sodium hyaluronate.
- 6. A process of preparing a wafer of viscoelastic material selected from the group consisting of chondroitin sulfate and a mixture of chondroitin sulfate and a hyaluronate, adapted to hold an intraocular lens comprising molding a solution of said viscoelastic material, and curing said molded material to produce a solid wafer.
- 7. The process set forth in claim 6, wherein said curing is by evaporation at ambient temperature.
- 8. The process set forth in claim 6, wherein said curing step is by evaporation at ambient temperature under laminar air flow.
CROSS-REFERENCE TO RELATED APPLICATION
This is a continuation-in-part of our prior application, Ser. No. 516,341, filed July 22, 1983, now abandoned, the entire specification of which is incorporated herein by reference.
US Referenced Citations (3)
Non-Patent Literature Citations (3)
Entry |
Healon (Sodium Hyaluronate) Product Monograph, (Pharmacia Laboratories). |
Chondron Product Monograph (Kaken Pharmaceutial Co., Ltd.). |
Drugs in Japan, Ethical Drug Edition, p. 216, (Japan Pharmaceutical Information Center 1975) (with English Translation). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
516341 |
Jul 1983 |
|